Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep M Llibre

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Journal of Clinical Medicine|December 7, 2019
Enhancement of Antiviral CD8<sup>+</sup> T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with PembrolizumabOscar Blanch-Lombarte, Cristina Gálvez, Boris Revollo, et al.
Plos One|August 8, 2013
Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory studyJosé R Santos, José A Muñoz-Moreno, José Moltó, et al.
HIV Medicine|May 1, 2024
Prevalence of people living with multidrug-resistant HIV and limited treatment options in SpainJosep M Llibre, Federico García, José Luis Blanco, et al.
Frontiers in Pediatrics|January 22, 2024
Corrigendum: Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendeesAndreu Colom-Cadena, Hector Martínez-Riveros, Anna Bordas, et al.
Annals of Internal Medicine|July 16, 2003
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trialJavier Martinez-Picado, Eugènia Negredo, Lidia Ruiz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2008
Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter studyVicenç Falcó, Montserrat Olmo, Sara Villar del Saz, et al.
The Lancet. Infectious Diseases|May 30, 2021
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trialBoris Revollo, Ignacio Blanco, Pablo Soler, et al.
Frontiers in Pediatrics|February 6, 2023
Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendeesAndreu Colom-Cadena, Héctor Martínez-Riveros, Anna Bordas, et al.
Lancet (London, England)|January 10, 2018
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studiesJosep M Llibre, Chien-Ching Hung, Cynthia Brinson, et al.
Plos Pathogens|November 3, 2011
Deep molecular characterization of HIV-1 dynamics under suppressive HAARTMaria J Buzón, Francisco M Codoñer, Simon D W Frost, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical Medicine|December 7, 2019
Enhancement of Antiviral CD8<sup>+</sup> T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with PembrolizumabOscar Blanch-Lombarte, Cristina Gálvez, Boris Revollo, et al.
Plos One|August 8, 2013
Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory studyJosé R Santos, José A Muñoz-Moreno, José Moltó, et al.
HIV Medicine|May 1, 2024
Prevalence of people living with multidrug-resistant HIV and limited treatment options in SpainJosep M Llibre, Federico García, José Luis Blanco, et al.
Frontiers in Pediatrics|January 22, 2024
Corrigendum: Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendeesAndreu Colom-Cadena, Hector Martínez-Riveros, Anna Bordas, et al.
Annals of Internal Medicine|July 16, 2003
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trialJavier Martinez-Picado, Eugènia Negredo, Lidia Ruiz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2008
Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter studyVicenç Falcó, Montserrat Olmo, Sara Villar del Saz, et al.
The Lancet. Infectious Diseases|May 30, 2021
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trialBoris Revollo, Ignacio Blanco, Pablo Soler, et al.
Frontiers in Pediatrics|February 6, 2023
Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendeesAndreu Colom-Cadena, Héctor Martínez-Riveros, Anna Bordas, et al.
Lancet (London, England)|January 10, 2018
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studiesJosep M Llibre, Chien-Ching Hung, Cynthia Brinson, et al.
Plos Pathogens|November 3, 2011
Deep molecular characterization of HIV-1 dynamics under suppressive HAARTMaria J Buzón, Francisco M Codoñer, Simon D W Frost, et al.
Pageof 17